19 June 2013
Keywords: neurocrine, oral, gnrh, antagonist, clears, ph, trial
Article | 13 May 2002
Neurocrine Biosciences of San Diego, USA, has reported that itsorally-active gonadotropin-releasing hormone antagonist has been able to
achieve target blood ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 May 2002
18 June 2013
© 2013 thepharmaletter.com